Top upgrades and downgrades on 7/15: QCOM, DAL, CSCO, DRE and more

Analysts Notebook wrote a column · Jul 15, 2022 07:38

Upgrades

• $Allogene Therapeutics (ALLO.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $32 (from $9)

• $ChampionX (CHX.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $22 (from $25)

• $CSX Corp (CSX.US)$ : Stifel Upgrades to Buy from Hold - PT $37 (from $39)

• $TechnipFMC (FTI.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $8 (from $9.50)

• $Norfolk Southern (NSC.US)$ : Stifel Upgrades to Buy from Hold - PT $275 (from $289)

• $Novo-Nordisk A/S (NVO.US)$ : Morgan Stanley Upgrades to Overweight from Equal Weight

• $ProFrac Holding (PFHC.US)$ : BofA Securities Upgrades to Neutral from Buy - PT $18 (from $26)

• $Qualcomm (QCOM.US)$ : Edward Jones Upgrades to Buy from Hold

Downgrades

• $Biotricity (BTCY.US)$ : Maxim Group Downgrades to Hold from Buy

• $Cisco (CSCO.US)$ : KGI Securities Downgrades to Neutral from Outperform - PT $59

• $Delta Air Lines (DAL.US)$ : Argus Downgrades to Hold from Buy

• $Duke Realty Corp (DRE.US)$ : Baird Downgrades to Neutral from Outperform - PT $74 (from $78)

• $F-star Therapeutics (FSTX.US)$ : H.C. Wainwright Downgrades to Neutral from Buy - PT $7 (from $35)

• $ManpowerGroup (MAN.US)$ : Truist Securities Downgrades to Hold from Buy - PT $80 (from $140)

• $Patterson-UTI Energy (PTEN.US)$ : BofA Securities Downgrades to Neutral from Buy - PT $13.50 (from $22)

• $Robert Half (RHI.US)$ : Truist Securities Downgrades to Hold from Buy - PT $66 (from $120)

• $10x Genomics (TXG.US)$ : BofA Securities Downgrades to Underperform from Neutral - PT $35 (from $80)

• $Yelp Inc (YELP.US)$ : Goldman Sachs Downgrades to Neutral from Buy - PT $33 (from $49)

Initiated

• $ACI Worldwide (ACIW.US)$ : Stephens initiates at Overweight - PT $31

• $American Financial (AFG.US)$ : Morgan Stanley initiates at Equalweight - PT $147

• $DoubleVerify (DV.US)$ : Goldman Sachs initiates at Buy - PT $30

• $DexCom (DXCM.US)$ : Bernstein initiates at Outperform - PT $105

• $Equity Lifestyle Properties Inc (ELS.US)$ : Wolfe Research initiates at Peerperform

• $IQVIA Holdings (IQV.US)$ : SVB Leerink initiates at Outperform - PT $256

• $Omnicell (OMCL.US)$ : SVB Leerink initiates at Market Perform - PT $124

• $OptimizeRx (OPRX.US)$ : SVB Leerink initiates at Outperform - PT $38

• $PROCEPT BioRobotics (PRCT.US)$ : KeyBanc initiates at Overweight - PT $47

• $Qualys (QLYS.US)$ : DA Davidson initiates at Neutral - PT $120

Moomoo Inc. ("moomoo") provides mobile and online technology solutions for securities trading. Moomoo is not an investment adviser or a broker-dealer and it provides neither investment or financial advice nor securities trading services. All contents such as comments and links posted or shared by users of the community are opinions of the respective authors only and do not reflect the opinions, views, or positions of moomoo, its affiliates, or any employees of moomoo or its affiliates. Please consult a qualified investment or tax advisor for your personal financial planning and tax situations.

Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only. Read more

Translate

Report

415K Views

Comment

RDK79 : Where was EJ when Qualcomm was at 118 last month. Now it’s back in the 140s and now they change to a ‘buy’. Most of these folks are useless and put out updates to keep a paycheck. No metrics or accountability for decades. What a job. Recession is usually the only filter.

Report
Reply

Cancel Reply

Analysts Notebook

Moomoo News Official Account

How do analysts evaluate the market?

18KFollowers

46Following

39KVisitors